The hepatitis C virus (HCV) is a major cause of chronic hepatitis, cirrhosis and
hepatocellular carcinoma worldwide. A significant portion of the morbidity and mortality …

Over the last years it has started a real revolution in the treatment of chronic hepatitis C. This
occurred for the availability of direct-acting antiviral agents that allow to reach sustained …

Background & Aims Prevention of hepatitis C virus (HCV) transmission among people who
inject drugs (PWID) is critical for eliminating HCV in Europe. We estimated the impact of …

The advent of potent and safe direct-acting antivirals against the hepatitis C virus has the
potential of fulfilling the dream of eliminating this infection and its impact on global public …

In dieser Leitlinie sind eingetragene Warenzeichen (geschützte Warennamen) nicht
besonders kenntlich gemacht. Es kann also aus dem Fehlen eines entsprechenden …

Utilizing genome-wide association studies (GWASs) to examine the variation in hepatitis C
virus (HCV) phenotypes has led to quantum improvements in our understanding of both the …

The opportunity to eliminate hepatitis C virus (HCV) is at hand, but challenges remain that
negatively influence progress through the care continuum, particularly for persons co …

Цель. Исследовать различия между контрастными по стадиям фиброза печени
группами пациентов в вирусологических показателях, в гуморальном ответе на …

Wirusowe zapalenie wątroby typu C (HCV) jest wywołane przez infekcję jednoniciowym,
otoczkowym wirusem RNA z rodziny Flaviviridae, rodzaju Hepacivirus. Infekcja HCV …

Les hépatites virales de type B et C sont une des principales causes de morbidité et
mortalité dans le monde [1-5]. En Europe, on estime qu'en 2010 l'hépatite B a causé environ …